Jamieson Wellness Announces Series A Preferred Share Redemption
Toronto, May 2025 – Jamieson Wellness Inc. (TSX: JWEL), a leading Canadian health and wellness company, announced a significant milestone in its international growth strategy with the upcoming redemption of 2,527,121 Series A Preference Shares. These shares, currently held by an affiliate of DCP Capital Partners (“DCP”), were originally issued in conjunction with DCP’s strategic investment in Jamieson’s China operations in 2023.
The redemption is scheduled to occur on or about June 4, 2025, marking the end of a two-year holding period stipulated in the agreement between the two parties. Jamieson will redeem the shares at a price of $40.19 per share, resulting in aggregate liquidation proceeds totaling approximately $101.6 million. This move reflects a pivotal financial event for the company, aligning with its longer-term growth strategy while maintaining a strong partnership with DCP.
The transaction follows the contractual structure agreed upon during DCP’s 2023 investment, which included provisions allowing for redemption of the Preference Shares following the second anniversary of the issue date. DCP, one of Asia’s most experienced private equity investors with a strong track record in consumer and health-related sectors, has played an integral role in advancing Jamieson’s expansion in the rapidly growing Chinese market.
In a statement accompanying the announcement, Hwan Yoon Chung, Managing Director at DCP, reaffirmed the firm’s belief in Jamieson Wellness and its continued growth prospects, especially in Asia’s burgeoning health and wellness sector. “As committed partners in Jamieson’s China business and warrant holders, we maintain strong conviction in the Company’s fundamentals and growth trajectory,” Chung said.
He continued, “Jamieson has established itself as a formidable brand in China, successfully capturing market share from long-standing incumbents. The strength of our collaboration has allowed us to build a world-class, high-performing team that is fully capitalizing on China’s dynamic and fast-evolving consumer health landscape. This redemption reflects the natural cadence of our fund’s mandated investment cycle, but it does not mark an end to our involvement. On the contrary, we’re excited to continue participating through our warrants and equity position in Jamieson’s Chinese business, where we see continued upside potential.”
DCP has a well-established history of investment in China’s health and wellness sector, with over three decades of experience supporting leading brands. Their ongoing collaboration with Jamieson positions both entities to take advantage of growing demand for vitamins, minerals, and supplements (VMS) in Asia and beyond.
Mike Pilato, President and CEO of Jamieson Wellness, echoed these sentiments and praised the partnership’s transformative impact. “Our relationship with DCP has been nothing short of pivotal in shaping Jamieson’s China growth story,” Pilato said. “In the first quarter of 2025 alone, our China business grew over 50%, building on the nearly 80% growth we achieved in 2024. This is not just a growth spike – it is the result of a well-executed, long-term strategy that is now bearing sustainable results.”
Pilato emphasized the unique strengths DCP brought to the table, especially their deep-rooted expertise in navigating China’s regulatory, digital, and consumer landscapes. “Together, we’ve established Jamieson as a highly respected brand in the world’s second-largest VMS market. Their insights into e-commerce platforms, digital marketing, and distribution networks have been instrumental in accelerating our brand’s reach and credibility,” he said.
He added, “The redemption of the Preference Shares was anticipated and included in our financial modeling for 2025. It does not alter our guidance or outlook. We remain firmly on track with our strategic objectives and are confident in the foundation we’ve built in China. The long-term outlook for this market is highly positive, and our collaboration with DCP—though evolving—remains central to our success going forward.”
Jamieson’s presence in China aligns with its broader global strategy of capturing market share in high-growth international markets. As health-conscious consumers across Asia increasingly turn to premium nutritional products, the company has positioned itself to meet that demand through localized product offerings, digital engagement, and robust distribution partnerships.
The successful scaling of Jamieson’s China business comes amid broader momentum across the global health and wellness sector. Analysts project continued growth in the VMS category, especially in emerging markets like China, where rising disposable income, aging demographics, and increased health awareness are fueling demand.
DCP’s exit from the Preference Shares is seen by analysts as a positive development that clears the capital structure while reinforcing Jamieson’s underlying value. The fact that DCP continues to hold warrants and maintain an equity interest signals strong confidence in Jamieson’s future trajectory.
Industry watchers also note that the redemption simplifies Jamieson’s shareholder base and may open doors for further strategic moves, whether in the form of new investments, acquisitions, or accelerated expansion into adjacent markets within Asia.
In concluding his remarks, Pilato expressed optimism about the road ahead: “As we look to the future, our strategy remains focused on sustainable, high-quality growth. With a solid operational base in China, strong partnerships, and an expanding global footprint, Jamieson is well positioned to lead the next wave of innovation and expansion in the global wellness category.”
About Jamieson Wellness Inc.
Jamieson Wellness is one of Canada’s most established and trusted names in natural health products. The company offers a wide range of premium nutritional supplements under its flagship Jamieson brand, as well as complementary products through its Progressive, Smart Solutions, and IronVegan brands. With a commitment to quality, innovation, and consumer health, Jamieson continues to grow its international presence while staying true to its Canadian roots.
About DCP Capital Partners
DCP Capital Partners is a leading private equity firm focused on investing in market-leading companies across Asia. With deep domain expertise in consumer health, retail, and industrial sectors, DCP has a proven history of creating value through operational improvements, strategic partnerships, and long-term investment vision. Its decades-long experience in China’s health and wellness sector makes it a valuable ally for brands seeking to scale in one of the world’s most dynamic markets.
